Innate immunity in donor procurement

Current Opinion in Organ Transplantation

Volumn 18, Issue 2, 2013, Pages 154-160

  Cheung, Kitty P ^a   Kasimsetty, Sashi G ^a   McKay, Dianne B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Inflammasome; Innate immune receptors; Kidney ischaemia reperfusion injury; NOD like receptor; Toll like receptor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD47 ANTIGEN; COMPLEMENT RECEPTOR; INFLAMMASOME; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

CELL ACTIVATION; CELL PROLIFERATION; DELAYED GRAFT FUNCTION; INNATE IMMUNITY; ISCHEMIC REPERFUSION INJURY; KIDNEY INJURY; KIDNEY ISCHEMIA; NATURAL KILLER T CELL; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

DELAYED GRAFT FUNCTION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KIDNEY; REPERFUSION INJURY; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84875387164     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835e2b0d     Document Type: Review

References (85)

1. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011;7: 189-200
2. Molitoris BA. Na-K-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol 1993;265:F693-697
3. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002;62: 1539-1549
4. Molitoris BA, Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 1999;106: 583-592
5. Basile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007;72: 151-156
6. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal ischemia/ reperfusion injury. J Clin Invest 2000;105: 1363-1371
7. Homeister JW, Lucchesi BR. Complement activation and inhibition in myocardial ischemia and reperfusion injury. Annu Rev Pharmacol Toxicol 1994;34: 17-40
8. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002;8: 582-587
9. Damman J, Hoeger S, Boneschansker L, et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol 2011;24: 233-237
10. Pushpakumar SB, Perez-Abadia G, Soni C, et al. Enhancing complement control on endothelial barrier reduces renal postischemia dysfunction. J Surg Res 2011;170:e263-e270
11. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 2009;130: 41-50
12. Ioannou A, Dalle Lucca J, Tsokos GC. Immunopathogenesis of ischemia/ reperfusion-associated tissue damage. Clin Immunol 2011;141: 3-14
13. Griffin MD. Mononuclear phagocyte depletion strategies in models of acute kidney disease: What are they trying to tell usöKidney Int 2012;82: 835-837
14. Wang Y, Wang YP, Zheng G, et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007;72: 290-299
15. Jo SK, Sung SA, Cho WY, et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006;21: 1231- 1239
16. Ferenbach DA, Sheldrake TA, Dhaliwal K, et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/ reperfusion injury in mice. Kidney Int 2012;82: 928-933
17. Li L, Huang L, Sung SS, et al. NKT cell activation mediates neutrophil IFNgamma production and renal ischemia-reperfusion injury. J Immunol 2007;178: 5899-5911
18. Gandolfo MT, Jang HR, Bagnasco SM, et al. Foxp3 regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009;76: 717- 729
19. Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009;20: 1744-1753
20. Kawasaki T, Kawai T, Akira S. Recognition of nucleic acids by patternrecognition receptors and its relevance in autoimmunity. Immunol Rev 2011;243: 61-73
21. Chung KY, Park JJ, Kim YS. The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate. Transplant Proc 2008;40: 2136-2138
22. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004;76: 514-519
23. Leventhal JS, Schroppel B. Toll-like receptors in transplantation: Sensing and reacting to injury. Kidney Int 2012;81: 826-832
24. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009;227: 248-263
25. Blasius AL, Beutler B. Intracellular Toll-like receptors. Immunity 2010;32: 305-315
26. Kawai T, Akira S. TLR signaling. Semin Immunol 2007;19: 24-32
27. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21: 317-337
28. Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol 2009;113:e1-e7
29. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003;2003:re3
30. Anders HJ, Banas B, Schlondorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004;15: 854-867
31. Tsuboi N, Yoshikai Y, Matsuo S, et al. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002;169: 2026-2033
32. Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 2006;21: 3062-3073
33. Benigni A, Caroli C, Longaretti L, et al. Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum 2007;56: 1569-1578
34. Shigeoka AA, Holscher TD, King AJ, et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 2007;178: 6252-6258
35. Chen J, John R, Richardson JA, et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2011;79: 288-299
36. Motojima M, Matsusaka T, Kon V, et al. Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Nephron Exp Nephrol 2010;114:e39-e47
37. Merkle M, Ribeiro A, Wornle M. TLR3-dependent regulation of cytokines in human mesangial cells: A novel role for IP-10 and TNF-alpha in hepatitis C-associated glomerulonephritis. Am J Physiol Renal Physiol 2011;301:F57-F69
38. Patole PS, Grone HJ, Segerer S, et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005;16: 1326-1338
39. Andersen-Nissen E, Hawn TR, Smith KD, et al. Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 2007;178: 4717-4720
40. Papadimitraki ED, Tzardi M, Bertsias G, et al. Glomerular expression of Tolllike receptor-9 in lupus nephritis but not in normal kidneys: Implications for the amplification of the inflammatory response. Lupus 2009;18: 831-835
41. Zhang D, Zhang G, Hayden MS, et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303: 1522-1526
42. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4: 499-511
43. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 2012;4: 1-18
44. Leemans JC, Stokman G, Claessen N, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005;115: 2894- 2903
45. Farrar CA, Keogh B, McCormack W, et al. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J 2012;26: 799-807
46. Arbibe L, Mira JP, Teusch N, et al. Toll-like receptor 2-mediated NF-kappaB activation requires a Rac1-dependent pathway. Nat Immunol 2000;1: 533- 540
47. Amura CR, Renner B, Lyubchenko T, et al. Complement activation and Tolllike receptor-2 signaling contribute to cytokine production after renal ischemia/ reperfusion. Mol Immunol 2012;52: 249-257
48. Sallustio F, De Benedictis L, Castellano G, et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J 2010;24: 514-525
49. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/ reperfusion injury. J Clin Invest 2007;117: 2847-2859
50. Wu H, Ma J, Wang P, et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010;21: 1878-1890
51. Rabadi MM, Kuo MC, Ghaly T, et al. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol 2012;302:F730-741
52. Allam R, Scherbaum CR, Darisipudi MN, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012;23: 1375-1388
53. Andrade-Oliveira V, Campos EF, Goncalves-Primo A, et al. TLR4 mRNA levels as tools to estimate risk for early posttransplantation kidney graft dysfunction. Transplantation 2012;94: 589-595
54. Kruger B, Krick S, Dhillon N, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 2009;106: 3390-3395
55. Lepenies J, Eardley KS, Kienitz T, et al. Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGFbeta (1) in patients with chronic kidney disease. Nephron Clin Pract 2011;119:c97-c104
56. Magalhaes JG, Sorbara MT, Girardin SE, et al. What is new with NodsöCurr Opin Immunol 2011;23: 29-34
57. Shaw PJ, Lamkanfi M, Kanneganti TD. NOD-like receptor (NLR) signaling beyond the inflammasome. Eur J Immunol 2010;40: 624-627
58. Shigeoka AA, Kambo A, Mathison JC, et al. Nod1 and Nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 2010;184: 2297-2304
59. Uehara A, Fujimoto Y, Fukase K, et al. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce antimicrobial peptides, but not proinflammatory cytokines. Mol Immunol 2007;44: 3100
60. Shigeoka AA, Mueller JL, Kambo A, et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 2010;185: 6277-6285
61. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol 2011;22: 1007-1018
62. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278: 8869-8872
63. Chamaillard M, Hashimoto M, Horie Y, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003;4: 702-707
64. Girardin SE, Boneca IG, Carneiro LA, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003;300: 1584- 1587
65. Le Bourhis L, Benko S, Girardin SE. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem Soc Trans 2007;35: 1479- 1484
66. Masumoto J, Yang K, Varambally S, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006;203: 203-213
67. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010;11: 373-384
68. Wilmanski JM, Petnicki-Ocwieja T, Kobayashi KS. NLR proteins: Integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol 2008;83: 13-30
69. Park JH, Kim YG, McDonald C, et al. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 2007;178: 2380-2386
70. Jin C, Frayssinet P, Pelker R, et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci U S A 2011;108: 14867-14872
71. Patschan D, Patschan S, Gobe GG, et al. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol 2007;18: 1516-1524
72. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364: 656-665
73. Grenz A, Osswald H, Eckle T, et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008;5:e137
74. Grenz A, Bauerle JD, Dalton JH, et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012;122: 693-710
75. Grenz A, Kim JH, Bauerle JD, et al. Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNFalpha release. J Immunol 2012;189: 4566-4573
76. Day YJ, Li Y, Rieger JM, et al. A2A adenosine receptors on bone marrowderived cells protect liver from ischemia-reperfusion injury. J Immunol 2005;174: 5040-5046
77. Day YJ, Huang L, McDuffie MJ, et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 2003;112: 883-891
78. Li L, Huang L, Ye H, et al. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 2012;122: 3931- 3942
79. Semenza GL. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88: 1474-1480
80. Hill P, Shukla D, Tran MG, et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008;19: 39-46
81. Conde E, Alegre L, Blanco-Sanchez I, et al. Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS One 2012;7:e33258
82. Jamadarkhana P, Chaudhary A, Chhipa L, et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am J Nephrol 2012;36: 208-218
83. Schley G, Klanke B, Schodel J, et al. Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J Am Soc Nephrol 2011;22: 2004-2015
84. Rogers NM, Thomson AW, Isenberg JS. Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury. J Am Soc Nephrol 2012;23: 1538-1550
85. Thakar CV, Zahedi K, Revelo MP, et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 2005;115: 3451-3459